Loading market data...
ai

Job titles of the future: Nature’s drug designer

MIT Tech ReviewPaywall
Read Full Article at MIT Tech Review
Share:PostShare
Ad Slot — In-Article (728x90)

In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use. For Merck, he’d developed precision therapies for cancer, HIV, and diabetes that could target disease while minimizing harm to healthy cells.

This is a summary. For the full story, read the original article at MIT Tech Review.

Original source: MIT Tech Review

Ad Slot — Below Article (300x250)